| Treatment for Patellofemoral Pain Syndrome Using Footwear (NCT01332110) | University of Calgary | 2011-06-01 |
| Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF (NCT01423851) | NS Pharma, Inc. | 2011-06-01 |
| The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia (NCT01065545) | Northwestern University | 2011-06-01 |
| Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms (NCT01328197) | Bolton Medical | 2011-06-01 |
| A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A (NCT01365520) | Novo Nordisk A/S | 2011-06-01 |
| Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] NKTR-118 (NCT01348724) | AstraZeneca | 2011-06-01 |
| Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet (NCT01383356) | Boehringer Ingelheim | 2011-06-01 |
| Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients. (NCT01051882) | Brainstorm-Cell Therapeutics | 2011-06-01 |
| Investigation Drug-drug Interaction Between Dabigatran and Clarithromycin (NCT01385683) | Centre Hospitalier Universitaire de Saint Etienne | 2011-06-01 |
| A Study of RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C (NCT01371162) | Hoffmann-La Roche | 2011-06-01 |
| To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin (NCT01363934) | Green Cross Corporation | 2011-06-01 |
| A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine (NCT01358968) | Eli Lilly and Company | 2011-06-01 |
| Bariatric Surgery Telemedicine Study (NCT01378897) | Baystate Medical Center | 2011-06-01 |
| Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects (NCT01411124) | XenoPort, Inc. | 2011-06-01 |
| Effect of Cilostazol on the Pharmacokinetics of Simvastatin (NCT01383395) | Samsung Medical Center | 2011-06-01 |
| Efficacy of a Brown Seaweed Extract Rich in Polyphenols on Glycemic Response to Sucrose in Human (NCT01384110) | innoVactiv Inc. | 2011-06-01 |
| Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil (NCT01369628) | EMD Serono | 2011-06-01 |
| Clinical Trial to Determine the MTD of HM781-36B in Patients With Advanced Solid Tumors (NCT01455584) | Hanmi Pharmaceutical Company Limited | 2011-06-01 |
| Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer (NCT01407341) | University of Southern California | 2011-06-01 |
| An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females (NCT01403038) | AbbVie (prior sponsor, Abbott) | 2011-06-01 |
| Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients (NCT01477697) | University of Cincinnati | 2011-06-01 |
| Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma (NCT02217956) | Gustave Roussy, Cancer Campus, Grand Paris | 2011-06-01 |
| Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV) (NCT01430195) | Clinuvel Pharmaceuticals Limited | 2011-06-01 |
| Doxazosin for Psychostimulant Dependence (NCT01371851) | University of Arkansas | 2011-06-01 |
| Effect Of Piperine In Patients With Oropharyngeal Dysphagia (NCT01383694) | Hospital de Mataró | 2011-06-01 |
| Two Clinical Trials to Evaluate Pharmacokinetics of Unboosted and Boosted Atazanavir Used Alone or Co-administered With Tenofovir DF in Healthy Korean and Caucasian Male Volunteers (NCT01368783) | Asan Medical Center | 2011-06-01 |
| Preventing Loss of Independence Through Exercise (PLIÉ) - Pilot (NCT01371214) | University of California, San Francisco | 2011-06-01 |
| Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV) (NCT02440074) | Red de Terapia Celular | 2011-06-01 |
| Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia (NCT01376076) | Forest Laboratories | 2011-06-01 |
| Oxytocin and Social Cognition (NCT01606462) | University Hospital, Bonn | 2011-06-01 |
| A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects (NCT01474941) | Pfizer | 2011-06-01 |
| Study of the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Alirocumab SAR236553 (REGN727) (NCT01448304) | Sanofi | 2011-06-01 |
| Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers (NCT01405612) | Norgine | 2011-06-01 |
| TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin (NCT01391117) | Tibotec BVBA | 2011-06-01 |
| A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors (NCT01358903) | Hoffmann-La Roche | 2011-06-01 |
| Fathers for Change for Men With Co-occurring Domestic Violence and Substance Abuse (NCT01385553) | Yale University | 2011-06-01 |
| Cochlear Implant PDA Based Research Platform (NCT01620385) | Philip Loizou | 2011-06-01 |
| First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4 (NCT01374503) | Ablynx, a Sanofi company | 2011-06-01 |
| Human Mass Balance Study of Pyronaridine (NCT01383109) | Medicines for Malaria Venture | 2011-06-01 |
| Safety Study of the Effect of Scelectium Tortuosum (as Zembrin®)in Aged Normals (NCT01805518) | Woodbury, Michel, M.D. | 2011-06-01 |
| Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer (NCT01376453) | H. Lee Moffitt Cancer Center and Research Institute | 2011-06-01 |
| Safety Study of Intranasal Oxytocin in Frontotemporal Dementia (NCT01386333) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2011-06-01 |
| Intra-arterial Chemotherapy for Children With Retinoblastoma (NCT00906113) | Hadassah Medical Organization | 2011-06-01 |
| Prefrontal Cortex Stimulation as Treatment for Crack-cocaine Addiction (NCT01337297) | Federal University of Espirito Santo | 2011-06-01 |
| Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and on CYP3A4/5 Metabolism in Healthy Volunteers (NCT01371006) | Boehringer Ingelheim | 2011-06-01 |
| A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet (NCT01388153) | Bayer | 2011-06-01 |
| A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma Concentration (NCT01403818) | Astellas Pharma Inc | 2011-06-01 |
| Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers (NCT01372761) | Zafgen, Inc. | 2011-06-01 |
| An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet (NCT01342198) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-06-01 |
| Improved Strategies for Outpatient Opioid Detoxification (NCT01377610) | New York State Psychiatric Institute | 2011-06-01 |
| A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler (NCT01371786) | Sumitomo Pharma America, Inc. | 2011-06-01 |
| Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid Tumors (NCT01340547) | Alaunos Therapeutics | 2011-06-01 |
| TF2- Small Cell Lung Cancer Radio Immunotherapy (NCT01221675) | Centre René Gauducheau | 2011-06-01 |
| Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease (NCT01397539) | Biogen | 2011-06-01 |
| Oral Selenium Therapy for the Prevention of Mucositis (NCT01432873) | Tehran University of Medical Sciences | 2011-06-01 |
| Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition (NCT01888224) | Dr. Reddy's Laboratories Limited | 2011-06-01 |
| Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies (NCT01353781) | AstraZeneca | 2011-06-01 |
| Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX (NCT01395667) | National Taiwan University Hospital | 2011-06-01 |
| Study of P3914 to Evaluate the Safety, Tolerability, Food Effect & Pharmacokinetics in Healthy Male Subjects and Efficacy & Safety of P3914 in Patients With Acute Dental Pain (NCT01339156) | Piramal Enterprises Limited | 2011-06-01 |
| A Study to Compare the Bioavailability of Copegus and Vilona® in Healthy Volunteers (NCT01615393) | Hoffmann-La Roche | 2011-06-01 |
| Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function (NCT01372826) | AstraZeneca | 2011-06-01 |
| Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers (NCT01348737) | AstraZeneca | 2011-06-01 |
| A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model (NCT01397227) | Crucell Holland BV | 2011-06-01 |
| A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects (NCT01427387) | Astellas Pharma Inc | 2011-06-01 |
| Ubiquitous Spaced Retrieval-based Memory Advancement and Rehabilitation Training (NCT01628653) | Seoul National University Bundang Hospital | 2011-06-01 |
| Resveratrol in Postmenopausal Women With High Body Mass Index (NCT01370889) | National Cancer Institute (NCI) | 2011-06-01 |
| Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001) (NCT01335191) | Thymon, LLC | 2011-06-01 |
| Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma (NCT01395485) | Amgen | 2011-06-01 |
| Effects of IGF-I in HIV Metabolic Disease (NCT01329744) | University of Texas Southwestern Medical Center | 2011-06-01 |
| SOM 230 and Gemcitabine in Advanced Pancreatic Cancer (NCT01385956) | H. Lee Moffitt Cancer Center and Research Institute | 2011-06-01 |
| An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors (NCT01413893) | AbbVie | 2011-06-01 |
| A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease (NCT01267994) | Andrea Vambutas | 2011-06-01 |
| Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) (NCT01110876) | M.D. Anderson Cancer Center | 2011-06-01 |
| Effects of Administration of Fostamatinib on Blood Concentrations of Digoxin in Healthy Subjects (NCT01355354) | AstraZeneca | 2011-06-01 |
| A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers (NCT01363999) | Hoffmann-La Roche | 2011-06-01 |
| A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects (NCT01403792) | University of Surrey | 2011-06-01 |
| CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells (NCT01373047) | Roger Williams Medical Center | 2011-06-01 |
| PATH Partnering to Achieve Tobacco-free Health (NCT01533974) | Fred Hutchinson Cancer Center | 2011-06-01 |
| Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM) (NCT01407003) | Novartis Pharmaceuticals | 2011-06-01 |
| Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects (NCT01359605) | Anthera Pharmaceuticals | 2011-06-01 |
| PDM08 Clinical Trial in Advanced Solid Tumors (NCT01380249) | Prodimed S.A. | 2011-06-01 |
| Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart (NCT01359618) | AstraZeneca | 2011-06-01 |
| A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes (NCT01976858) | Jiangsu HengRui Medicine Co., Ltd. | 2011-06-01 |
| Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas (NCT01058850) | Paul Graham Fisher | 2011-06-01 |
| Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers (NCT01374802) | Boehringer Ingelheim | 2011-06-01 |
| Manuka Honey Irrigation After Sinus Surgery (NCT01350193) | St. Paul's Hospital, Canada | 2011-06-01 |
| Hyperbaric Oxygen Therapy in Diabetics With Chronic Foot Ulcers and Improvement of Quality of Life (NCT02328508) | Chen-Yu Chen | 2011-06-01 |
| A Study on the Interaction Between Danoprevir/Ritonavir and Methadone (NCT01389544) | Hoffmann-La Roche | 2011-06-01 |
| Photodynamic Therapy for the Treatment of Vertebral Metastases (NCT02464761) | Sunnybrook Health Sciences Centre | 2011-06-01 |
| Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors (NCT01381822) | Threshold Pharmaceuticals | 2011-06-01 |
| A Study to Investigate the Effects of Food and Morning Versus Evening on Single and Multiple Doses of ONO-5334 in Healthy Post Menopausal Women (NCT01384188) | Ono Pharmaceutical Co., Ltd. | 2011-06-01 |
| A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Subjects (NCT01374178) | Eli Lilly and Company | 2011-06-01 |
| Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer (NCT01326481) | Tracon Pharmaceuticals Inc. | 2011-06-01 |
| Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets (NCT01366547) | ViiV Healthcare | 2011-06-01 |
| CKD-828 Drug Interaction Study (Telmisartan) (NCT01356017) | Chong Kun Dang Pharmaceutical | 2011-06-01 |
| Safinamide Renal Impairment Trial (NCT01374113) | Newron Pharmaceuticals SPA | 2011-06-01 |
| Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder (NCT01380704) | AbbVie | 2011-06-01 |
| Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis (NCT01340586) | Bristol-Myers Squibb | 2011-06-01 |
| Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir (NCT01382238) | ViiV Healthcare | 2011-06-01 |
| Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer (NCT01383668) | Mayo Clinic | 2011-06-01 |